Durect Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include Sucampo Pharmaceuticals, Biofrontera, Avid Bioservices and BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Sucampo Pharmaceuticals Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis. |  Biofrontera Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics. |  Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ||
Founding Date | Founding Date N/A | Founding Date 1996 | Founding Date 2012 | Founding Date 1981 | Founding Date 1948 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cupertino, US HQ | Locations Rockville, US HQ Chiyoda, JP Chuo Ward, JP Kita Ward, JP Sanda Shi, JP Zug, CH Milton, GB | Locations Leverkusen, DE HQ | Locations Tustin, US HQ | |
Employees | Employees 902% increase | Employees 37 | Employees 91 | Employees 21114% increase | Employees 650 |
Valuation ($) | Valuation ($) 45.3 m | Valuation ($) N/A | Valuation ($) 1.1 m | Valuation ($) 649.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) $230.1m (FY, 2016) | Revenue (est.) €13.2m (FY, 2025) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods $76m (FY, 2016) | Cost of goods €2.2m (FY, 2025) | Cost of goods $132.6m (FY, 2024) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit $154.1m (FY, 2016) | Gross profit €11.2m (FY, 2025) | Gross profit $7.3m (FY, 2024) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($8.3m) (FY, 2024) | Net income $18.5m (FY, 2016) | Net income (€6.9m) (FY, 2025) | Net income ($140.8m) (FY, 2024) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile
View Company Profiles
Sucampo Pharmaceuticals
HQ
Rockville, US
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
View companyBiofrontera
HQ
Leverkusen, DE
Employees
91
Biofrontera is a biopharmaceutical company that specializes in the development and commercialization of dermatological medications and medical cosmetics.
View companyAvid Bioservices
HQ
Tustin, US
Employees
211↑ 14% increase
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company